Presented during Poster Grand Rounds at the Annual Scientific Meeting and Postgraduate Course Program, Southeastern Surgical Congress, Savannah, GA, February 10–13, 2007.
Get full access to this article
View all access options for this article.
References
1.
KenetG., WaldenR., EldadA., MartinowitzU.Treatment of traumatic bleeding with recombinant factor VIIa.Lancet1999; 354: 1879.
2.
MartinowitzU., KenetG., SegalE.Recombinant activated factor VII for adjunctive hemorrhage control in trauma.J Trauma2001; 51: 431–9.
3.
O'NeillP.A., BluthM., GlosterE.S.Successful use of recombinant activated factor VII for trauma-associated hemorrhage in a patient without preexisting coagulopathy.J Trauma2002; 52: 400–5.
4.
MartinowitzU., KenetG., LubetskiA.Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.Can J Anaesth2002; 49: S15–20.
5.
DuttonR.P., HessJ.R., ScaleaT.M.Recombinant factor VIIa for control of hemorrhage: Early experience in critically ill trauma patients.J Clin Anesth2003; 15: 184–8.
6.
DuttonR.P., McCunnM., HyderM.Factor VIIA for correction of traumatic coagulopathy.J Trauma2004; 57: 709–18.
7.
FriedrichP.W., HennyC.P., MesselinkE.J.Effect of rF-VIIa on perioperative blood loss in patients undergoing retropubic prostectomy.Lancet2003; 361: 201–5.
8.
BoffardD., WarrenB.Decreased transfusion utilization and improved outcome associated with the use of recombinant factor VIIa as an adjunct in trauma.J Trauma2004; 57: 451.
